Clinical Research Directory
Browse clinical research sites, groups, and studies.
Screening for Chronic Liver Diseases in General Population
Sponsor: University Hospital, Montpellier
Summary
Improving the care of patients with liver diseases in primary care and will allow patients with chronic liver disease to benefit from a course appropriate care.
Official title: Non-invasive Screening for Chronic Liver Diseases in the General Population. A Prospective Study
Key Details
Gender
All
Age Range
40 Years - Any
Study Type
INTERVENTIONAL
Enrollment
260
Start Date
2024-09-11
Completion Date
2029-01-01
Last Updated
2025-07-10
Healthy Volunteers
No
Conditions
Interventions
Blood sample then fibroscan
The patient takes a blood test if none less than 6 months old is available, including a complete blood count (CBC) and a hepatic check. The FIB-4 score will be calculated from this blood test. If the result of the FIB-4 test is greater than 1.3 the person will be contacted by the SELHV (Service Expert de Lutte contre les Hépatites Virales) of the University Hospital of Montpellier in order to schedule, if she wishes, a second non-invasive screening examination of liver fibrosis by Fibroscan.
Locations (1)
CHU de Montpellier
Montpellier, France